Member Info for troutisout

Now you know why it was pushed up....To rinse the holders....

Slurm,
"Last few days there have been more sales than buys yet the SP is going up"
29/4 4.2m buys 73k sells
30/4 3.8m buys 3.1m sells
1/5 4m buys 315k sells
4/5 3.9m buys 860k sells
5/5 1m buys 5m sells
6/5 841k buys 384k sells

Slurm,
As I touched on, any JV will likely be at a different level now due to the COVID effects Worldwide, so that would also see my holding diluted, my share of the company remains the same but my share of the value of the company will be smaller.

Slurm
I will stick with what I said, that a JV would be dilutive (I never said share dilution), however as share holders we would own less of LC than we did before, so the effect on my personal holding in the company would be dilutive. I haven't reduced anything....

DVH, Not sure anything that was thought before COVID can be assumed to be the same now. Finances will be stretched, markets changed and costs and values of product will be different.
Any joint venture will probably be on different terms to what was discussed before COVID, it is becoming clearer that a V shaped recovery for the World economy is unlikely, as this is going to be a much longer process than politicians first thought. NAE might not have the luxury of having it kicked down the road and as pointed out they have the option to take stock instead.

Interview with CEO

tinyurl.com/y7akw8a9

https://www.crawleyobserver.co.uk/news/people/first-several-hundred-vital-nhs-ventilators-delivered-crawley-firm-2665941

So at £3.5m for UK and Ireland and £35m for global revenues, this looks to be a decent revenue stream for IHC. Unlike a normal Distributor, IHC are tasked with introducing the test to it's network of experts and opinion leaders to get acceptance of the test as the standard of care in Neonatal ICUs so I would hope they will receive a greater margin than just for distributing the products. Not sure this news has sunk in, looking at the current SP.

From the IHC RNS,
"Neil Campbell, Chief Executive Officer of Inspiration Healthcare commented "We are delighted to be able to work with genedrive plc with this novel testing device for new born babies that could suffer hearing loss due to anti-biotics given to them on admission into neonatal intensive care. Our focus has always been products that can have a profound effect on the patient outcome and we look forward to working with genedrive to make this test the standard of care in the UK and the wider neonatal community around the world."

"David Budd, Chief Executive Officer of genedrive plc, said: "Our agreement with Inspiration Healthcare combines genedrive's innovative first-to-market AIHL product, with a thought leading healthcare company with a specialist emphasis on neonatal care. Inspiration Healthcare has a strong track record in the introduction of new technologies and over many years they have developed an extensive network of key opinion leaders that will be very beneficial as we bring the Genedrive AIHL test to market together."

This was in the Genedrive placing RNS today, note the projected revenues for this test.

"Antibiotic-Induced Hearing Loss ("AIHL")
Around one in 500 infants carry a genetic mutation that's puts them at risk of suffering lifelong profound hearing loss after exposure to gentamycin, a commonly used antibiotic. genedrive has developed world's first rapid point-of-care genetic test for neonatal intensive care. There are no other point-of-care tests commercially available for AIHL and the Directors believe genedrive's test could support a new standard of care for all urgent case infants.

genedrive's AIHL test has a high clinical accuracy with 100% sensitivity and 100% specificity. Implementation trials for the test are progressing at Manchester and Liverpool but, as announced on 25 March 2020, have not been able to continue at the same pace as previous months as a result of NHS resources being diverted to address COVID-19.

On 24 April 2020, genedrive announced that it had entered into a distribution agreement with Inspiration Healthcare Group plc for the distribution of genedrive's AIHL test in the UK and Ireland. The Directors estimate the UK and global markets for this test to be worth up to £3.5 million and £35 million per year, respectively, to genedrive based on a price of £2,000 per Genedrive® unit and £35 per test."

Slurm,
I tend to agree with Sammybow,
The cost will be dilution, unless there is an advance payment for an offtake deal. I have thought long and hard about that scenario and I can't see it happening due to change in the World economic outlook, the need for more confirmation that LC can deliver the amounts needed and if it was a possibility why haven't they done it already? So I see it as being a JV and that would be dilutive compared with SML going it alone. However it wouldn't go at all if funds aren't forthcoming from the Cobre Major Client.
I agree they could defer Redmoor advancement, I am not sure how any deferring of payment would be received by NAE (again due to the World situation, they may want that cash now).
I tend to disagree about cash situation, if indeed they have paid the April instalment it will be around £150k, they might be able to keep the lights on but nothing else would be done with that sort of investment buffer...

There were two 55k trades on the 27th and 28th of last month as well.
Looks like lots of small sells being squeezed out by the price action and big lumpy trades picking them up.

There was me thinking all the extra posts might have included some new important news or research about DKE....

'of your post'

Hi Prop,
They RNSed the early October payment, that was a PR exercise, perhaps now they ought to think about PR this time round. Especially as putting both parts of post together suggest we are now running on just over £100k cash, with no early payment from the major client.

Did we pay the latest instalment or have they deferred it? We are really getting to the financial crux now.
Arbitration result could go many ways, winning that doesn't necessarily mean we get compensated by the major client.
If we do get some, it will be off to the races from these levels.
If we recover lots then off to the moon.
However if we don't recover anything then plan b, c and d might have to come into play and at this time we just don't know how they will pan out...

There are lots of trading stock to play with at the moment, great fun when they go up, not so great when they go down. So a sensible approach is to play with some of your capital and also note the Companies that are going to grow in the long term (Investments).
Lockdown has given us the next dotcom boom, plenty of people thinking they are trading geniuses, it isn't too hard to pick a stock and ride the wave, but there will be some almighty falls, where some will lose their shirts as they over extend as the SP's rise.
We haven't been long into this crisis, but we have already seen ventilator manufacturers be told their product isn't up to scratch or is no longer needed. Testing has now become the new goldmine, but just like ventilators, many tests won't get approval and once the big boys get their tests and vaccines in the market the smaller companies will find they are sidelined. Collaborations may help, but nothing is certain.
If and when a vaccine is produced then tests for COVID19 will cease to be needed in any large number. In the meantime some of these smaller companies are neglecting their other products, R&D, sales and marketing. So there will be positive and negative balances and only the ones who successfully monetise any COVID offering will have the positives to balance and hopefully outweigh the negatives....

Well there is still a buying op here, as others chase rainbows elsewhere.
This is confirmation of the start of delivery of concrete NHS orders that the Company have received.... £5.25m in total....
Also cannot emphasize enough the 24 hour helpline, this will put Inspiration Healthcare at the forefront of the minds of all the frontline staff in these critical care settings all over the country.
"In the last few days, Inspiration Healthcare has also extended its 24 hour helpline facility to give clinical staff at all UK hospitals access to qualified personnel employed by Inspiration who are able to give instructions on setting up of ventilators correctly and also to deal with any other issues which may arise during their use"

Well it would seem to be encouraging sellers and discouraging buyers, but it is certainly making the situation far from transparent. We have to remember they had some recent spikes and the MMs may still have be short on their book so they need more stock before releasing it.
If you look at the 6 month chart you can see that the past 6 weeks resembles a coiled spring, with a clear downtrend from the spikes and a clear uptrend from the troughs, these lines are rapidly converging and at one point the SP will have to attempt to breakout of this pattern.

I have been watching this for a few days now, loads of small sells, often matched with larger buys, the 55k trade looked like it was filled from the small sellers.
Looking at the chart I see 60p level as one where the the price should bounce, there have been a lot more bigger buys today (they don't seem to come into the trades data on this site - delayed, trades, mid price let alone the usual buys below mid price).
On that note it is 60.4p to buy even with the tick ups, 60.3p to sell so very tight spread and buys can take advantage. MMs seem to want to put a lid on buying with the false wide spread...

Not on AIM , listed on Main Market.